Should I buy or sell BioSig Technologies stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSGM shares. View BSGM analyst ratings or view top-rated stocks .

What is BioSig Technologies' stock price target for 2024?

2 brokers have issued twelve-month price objectives for BioSig Technologies' stock. Their BSGM share price targets range from $5.00 to $5.00. On average, they predict the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 1,512.9% from the stock's current price. View analysts price targets for BSGM or view top-rated stocks among Wall Street analysts .

How have BSGM shares performed in 2023?

BioSig Technologies' stock was trading at $0.42 at the beginning of 2023. Since then, BSGM stock has decreased by 26.2% and is now trading at $0.31. View the best growth stocks for 2023 here .

When is BioSig Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024. View our BSGM earnings forecast .

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) released its earnings results on Thursday, March, 31st. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.02. BioSig Technologies had a negative net margin of 9,336.04% and a negative trailing twelve-month return on equity of 8,125.85%.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD) , Inovio Pharmaceuticals (INO) , Pfizer (PFE) , Roku (ROKU) , Advanced Micro Devices (AMD) , Amarin (AMRN) , Dynavax Technologies (DVAX) , Vaxart (VXRT) , Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU) .

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Advisor Resource Council (1.44%), PFG Investments LLC (0.19%), Warberg Asset Management LLC (0.09%), Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner , Patrick Joseph Gallagher and Steve Chaussy . View institutional ownership trends .

BioSig Technologies Stock Price, News & Analysis (NASDAQ:BSGM)

$0.31

+0.00 (+0.91%)

(As of 11:45 AM ET)

Compare

Today's Range: $0.30
▼
$0.32
50-Day Range: $0.31
▼
$0.63
52-Week Range: $0.28
▼
$1.65

Volume: 23,826 shs
Average Volume: 445,634 shs
Market Capitalization: $27.31 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.00

BioSig Technologies MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 1,512.9% Upside
$5.00 Price Target
Short Interest: Healthy
2.30% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.21
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

Medical Sector

760th out of 935 stocks

Electromedical Equipment Industry

17th out of 22 stocks

3.5

Analyst's Opinion

Consensus Rating
BioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $5.00, BioSig Technologies has a forecasted upside of 1,512.9% from its current price of $0.31.
Amount of Analyst Coverage
BioSig Technologies has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
2.30% of the outstanding shares of BioSig Technologies have been sold short.
Short Interest Ratio / Days to Cover
BioSig Technologies has a short interest ratio ("days to cover") of 6.9.
Change versus previous month
Short interest in BioSig Technologies has recently decreased by 13.98%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
BioSig Technologies does not currently pay a dividend.
Dividend Growth
BioSig Technologies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BSGM.

4.0

News and Social Media Coverage

News Sentiment
BioSig Technologies has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for BioSig Technologies this week, compared to 0 articles on an average week.
Search Interest
5 people have searched for BSGM on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
MarketBeat Follows
2 people have added BioSig Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BioSig Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 9.30% of the stock of BioSig Technologies is held by insiders.
Percentage Held by Institutions
Only 7.16% of the stock of BioSig Technologies is held by institutions.

0.0

Earnings and Valuation

Price to Book Value per Share Ratio
BioSig Technologies has a P/B Ratio of 31.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About BioSig Technologies Stock (NASDAQ:BSGM)

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BSGM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BSGM Stock News Headlines

November 27, 2023 | msn.com

Biosig Technologies (BSGM) Price Target Increased by 38.89% to 5.74

November 18, 2023 | americanbankingnews.com

Head to Head Review: BioSig Technologies (NASDAQ:BSGM) and Semler Scientific (NASDAQ:SMLR)

November 28, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 9, 2023 | msn.com

BioSig announces $2.5M registered direct offering priced at-the-market under Nasdaq rules

November 9, 2023 | finance.yahoo.com

BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

September 6, 2023 | benzinga.com

BioSig – Medical Device Maker Is Revolutionizing How Arrhythmias Are Treated

August 25, 2023 | finance.yahoo.com

BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model

August 24, 2023 | finance.yahoo.com

BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals

November 28, 2023 | Edge On The Street (Ad)

Americans Now Favor Gold Over Stocks as an Investment Vehicle

Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.

August 16, 2023 | finance.yahoo.com

BioSig Technologies Second Quarter 2023 Earnings: US$0.16 loss per share (vs US$0.15 loss in 2Q 2022)

July 25, 2023 | finance.yahoo.com

BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications

July 21, 2023 | finance.yahoo.com

NVIDIA Inception Chooses BioSig AI For Innovation In Healthcare AI, An Industry That Is Projected To Reach $272.9 Billion By 2030

July 20, 2023 | theglobeandmail.com

Healthcare Shares Bid Up Following Major Premarket Announcement

July 20, 2023 | markets.businessinsider.com

Why Is BioSig Technologies (BSGM) Stock Up 19% Today?

July 20, 2023 | finance.yahoo.com

BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals

June 29, 2023 | finance.yahoo.com

BioSig Joins Webull Corporate Connect

June 27, 2023 | finance.yahoo.com

BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare

May 24, 2023 | benzinga.com

New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market

May 19, 2023 | finance.yahoo.com

New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias

May 16, 2023 | investing.com

Biosig Tech (BSGM) Earnings Dates & Reports

March 27, 2023 | finance.yahoo.com

BioSig Announces New Advisory Board Member Edwin Wang

March 24, 2023 | finance.yahoo.com

BioSig Announces New Advisory Board Member Lorraine Spurge

March 13, 2023 | finance.yahoo.com

BioSig Confirms No Exposure to Silicon Valley Bank

February 22, 2023 | finance.yahoo.com

BioSig Regains Compliance With All Nasdaq Listing Standards

February 22, 2023 | finance.yahoo.com

BioSig Regains Compliance With All Nasdaq Listing Standards

February 17, 2023 | finance.yahoo.com

BioSig Awarded US Patent Claims for its Universal Notch Filter Technology

February 7, 2023 | msn.com

BioSig names Steve Buhaly CFO replacing Chaussy

See More Headlines

Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/31/2022
Today: 11/28/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/13/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electromedical equipment
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:BSGM
CUSIP: N/A
CIK: 1530766
Web: www.biosig.com
Phone: (230) 409-5444
Fax: N/A
Employees: 47
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $5.00
High Stock Price Target: $5.00
Low Stock Price Target: $5.00
Potential Upside/Downside: +1,527.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-27,050,000.00
Net Margins: -9,336.04%
Pretax Margin: -20,963.12%
Return on Equity: -8,125.85%
Return on Assets: -727.39%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.27
Quick Ratio: 0.21

Sales & Book Value

Annual Sales: $290,000.00
Price / Sales: 93.34
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.01 per share
Price / Book: 30.72

Miscellaneous

Outstanding Shares: 88,110,000
Free Float: 79,914,000
Market Cap: $27.07 million
Optionable: Not Optionable
Beta: 1.29

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Kenneth L. Londoner M.B.A. (Age 55)
Founder, CEO & Executive Chairman
Comp: $1.17M
Mr. John Sieckhaus (Age 55)
Chief Operating Officer
Comp: $282.52k
Mr. Michael Graydon Fleming Jr. (Age 49)
Chief Commercial Officer
Comp: $400k
Mr. Frederick D. Hrkac (Age 57)
Executive VP & Director
Comp: $15k
Mr. Steven J. Buhaly (Age 66)
Chief Financial Officer
Dr. Budimir S. Drakulic Ph.D. (Age 73)
Chief Scientist
Comp: $169.64k
Mr. Andrew Gornell Ballou
Vice President of Investor Relations
Ms. Brenda Castrodad
Vice President of Human Resources

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BSGM Stock Analysis - Frequently Asked Questions

Should I buy or sell BioSig Technologies stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSGM shares.
View BSGM analyst ratings or view top-rated stocks.
What is BioSig Technologies' stock price target for 2024?: 2 brokers have issued twelve-month price objectives for BioSig Technologies' stock. Their BSGM share price targets range from $5.00 to $5.00. On average, they predict the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 1,512.9% from the stock's current price.
View analysts price targets for BSGM or view top-rated stocks among Wall Street analysts.
How have BSGM shares performed in 2023?: BioSig Technologies' stock was trading at $0.42 at the beginning of 2023. Since then, BSGM stock has decreased by 26.2% and is now trading at $0.31.
View the best growth stocks for 2023 here.
When is BioSig Technologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our BSGM earnings forecast.

How were BioSig Technologies' earnings last quarter?: BioSig Technologies, Inc. (NASDAQ:BSGM) released its earnings results on Thursday, March, 31st. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.02. BioSig Technologies had a negative net margin of 9,336.04% and a negative trailing twelve-month return on equity of 8,125.85%.
What other stocks do shareholders of BioSig Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).
Who are BioSig Technologies' major shareholders?: BioSig Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Advisor Resource Council (1.44%), PFG Investments LLC (0.19%), Warberg Asset Management LLC (0.09%), Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy.
View institutional ownership trends.
How do I buy shares of BioSig Technologies?: Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BSGM) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial